{"Q": 1, "answer": "no", "rationale": "The segment describes financial movement and a deal, not intensified or comparative risk-adjectives.", "method": "llm_batch", "batch_id": "batch_1_7516", "batch_size": 260, "batch_pos": 211, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses a vivid verb ('climbed') but it describes a background economic trend, not the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_6128", "batch_size": 260, "batch_pos": 193, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Financial metrics are Neutral (rule 6).", "method": "llm_batch", "batch_id": "batch_3_15600", "batch_size": 260, "batch_pos": 173, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14580", "batch_size": 260, "batch_pos": 164, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports financial news and a potential deal, which is not an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_16156", "batch_size": 260, "batch_pos": 163, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_14608", "batch_size": 260, "batch_pos": 154, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation about the virus or situation.", "method": "llm_batch", "batch_id": "batch_7_3968", "batch_size": 260, "batch_pos": 148, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "regex:CapabilityNoReassurance matched", "method": "regex", "batch_id": "batch_8_13304", "batch_size": 260, "batch_pos": 86, "regex": {"rule": "CapabilityNoReassurance", "span": [178, 185], "captures": []}, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
